Answers are grounded in this paper and cite their sources.
TATA-binding protein-associated factor 15 (TAF15), a key member of the FET family, is an RNA-binding protein extensively involved in RNA transcription, splicing, and transport. In recent years, a growing number of studies have shown that aberrant TAF15 expression is closely associated with the initiation and progression of various diseases, particularly exerting critical regulatory effects in inflammatory diseases and tumor progression. In inflammatory diseases, TAF15 not only contributes to the pathology of metabolic dysfunction-associated steatohepatitis (MASH, formerly known as NASH) but also plays a significant role in multiple systemic inflammatory conditions, including pulpitis, knee osteoarthritis, sepsis-associated lung injury, and diabetic foot ulcers. This suggests its potential to drive disease progression by modulating inflammatory responses. In cancer, TAF15 displays even broader involvement. In digestive system tumors, it is closely linked to the pathogenesis of hepatocellular carcinoma, intrahepatic cholangiocarcinoma, gastric cancer, esophageal cancer, pancreatic cancer, and colorectal cancer. In respiratory system tumors, it participates in the malignant progression of lung cancer and nasopharyngeal carcinoma. Moreover, TAF15 is implicated in the development and progression of female-specific tumors (breast cancer, cervical cancer, and ovarian cancer), skin tumors (melanoma and cutaneous squamous cell carcinoma), and nervous system tumors (brain glioma). In summary, through complex molecular mechanisms, TAF15 exerts pro-inflammatory or pro-oncogenic effects in multisystem inflammatory diseases and tumors. While it shows potential as a candidate biomarker and therapeutic target, further in-depth investigation of its regulatory networks and extensive clinical validation are imperative before clinical translation.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: